|Place of Origin:||CHINA|
|Model Number:||Antineoplastic Drugs API - 67|
|Minimum Order Quantity:||1KG|
|Packaging Details:||Aluminum foil bag, fiber can, kraft paper bag|
|Delivery Time:||Within 7 days|
|Supply Ability:||Can be customized according to customer requirements|
chemical raw materials,
pharmaceutical raw materials
Sorafenib tosylate CAS 475207-59-1 Pharmaceutical Grade Chemicals
Sorafenib tosylate is a novel multi-target anti-tumor drug developed by Bayer Pharmaceuticals, Germany, which acts on both tumor cells and tumor blood vessels. It has a dual anti-tumor effect: it directly inhibits tumor cell proliferation by blocking the RAF/MEK/ERK-mediated cell signaling pathway, and also inhibits VEGF and platelet-derived growth factor (PDGF) receptors. Blocking the formation of tumor neovascularization, indirectly inhibiting the growth of tumor cells.
1. Treatment of inoperable advanced renal cell carcinoma.
2. Treatment of primary HCC that cannot be operated on or metastasized.
We can customize according to customer's requirement.
If you have any question pls mail us or call us.